Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Core Viewpoint - Sight Sciences, Inc. will report its financial results for Q4 and the full year ended December 31, 2025, on March 4, 2026, with a conference call scheduled for 1:30 PM PT / 4:30 PM ET [1] Company Overview - Sight Sciences is an eyecare technology company focused on developing innovative interventional solutions to transform care and improve patients' lives [3] - The company utilizes minimally invasive or non-invasive approaches to address prevalent eye diseases, aiming to enhance patient care and replace outdated treatment methods [3] - Key products include the OMNI Surgical System and OMNI Edge Surgical System for glaucoma treatment, and the TearCare System for evaporative dry eye disease [3] Product Details - The OMNI Surgical System is designed to reduce intraocular pressure in adult patients with primary open-angle glaucoma and is CE Marked for specific surgical procedures [3] - The SION Surgical System is a bladeless device for excising trabecular meshwork in ophthalmic surgeries [3] - The TearCare System is 510(k) cleared in the U.S. for localized heat therapy to treat meibomian gland disease, a leading cause of dry eye disease [3]